Direct evidence to support the role of antigen-specific CD8+ T cells in melanoma-associated vitiligo

被引:82
作者
Le Gal, FA
Avril, MF
Bosq, J
Lefebvre, P
Deschemin, JC
Andrieu, M
Dore, MX
Guillet, JG
机构
[1] Inst Cochin Genet Mol, INSERM, U445, Dept Immunol,Lab Pathol Infect & Tumorales, F-75014 Paris, France
[2] Inst Gustave Roussy, Serv Dermatol, F-94805 Villejuif, France
[3] Inst Gustave Roussy, Dept Anatomopathol, F-94805 Villejuif, France
关键词
melanoma; skin; T lymphocytes; tumor immunity; vitiligo;
D O I
10.1046/j.0022-202x.2001.01605.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Vitiligo is a cutaneous pigmentary disorder characterized by the loss of melanocytes. An autoimmune mechanism is strongly suspected to be involved in this affection given that it is frequently associated with autoimmune hormonal disorders, and because antibodies directed against melanocytic antigens are found in the serum of patients with vitiligo. We examined the role of cellular immunity in melanoma-associated vitiligo by expanding infiltrating lymphocytes from fresh biopsy specimens of vitiligo patches in melanoma patients. The vitiligo-infiltrating lymphocytes were almost exclusively T lymphocytes, and most were CD8(+). Following in vitro expansion, vitiligo-infiltrating lymphocytes remained predominantly CD8(+) and expressed the cutaneous homing receptor CLA. Furthermore, vitiligo-infiltrating lymphocytes had a clonal or oligoclonal T cell receptor profile, possibly reflecting specific antigenic stimulation. Finally, vitiligo-infiltrating lymphocytes specifically recognized differentiation antigens shared by normal melanocytes and melanoma cells. This direct demonstration of CD8(+) T cell involvement in vitiligo suggests that, in melanoma patients, vitiligo may be a visible effect of a spontaneous antitumoral immune response.
引用
收藏
页码:1464 / 1470
页数:7
相关论文
共 40 条
[1]   AN IMMUNOHISTOLOGICAL STUDY OF CUTANEOUS LYMPHOCYTES IN VITILIGO [J].
ALBADRI, AMT ;
TODD, PM ;
GARIOCH, JJ ;
GUDGEON, JE ;
STEWART, DG ;
GOUDIE, RB .
JOURNAL OF PATHOLOGY, 1993, 170 (02) :149-155
[2]   Tyrosinase as an autoantigen in patients with vitiligo [J].
Baharav, E ;
Merimski, O ;
Shoenfeld, Y ;
Zigelman, R ;
Gilbrud, B ;
Yecheskel, G ;
Youinou, P ;
Fishman, P .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 105 (01) :84-88
[3]   Accumulation of identical T cells in melanoma and vitiligo-like leukoderma [J].
Becker, JC ;
Guldberg, P ;
Zeuthen, J ;
Bröcker, EB ;
Straten, PT .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 113 (06) :1033-1038
[4]   CD4+ T-cell memory, CD45R subsets and the persistence of antigen - a unifying concept [J].
Bell, EB ;
Sparshott, SM ;
Bunce, C .
IMMUNOLOGY TODAY, 1998, 19 (02) :60-64
[5]   A tyrosinase nonapeptide presented by HLA-B44 is recognized on a human melanoma by autologous cytolytic T lymphocytes [J].
Brichard, VG ;
Herman, J ;
VanPel, A ;
Wildmann, C ;
Gaugler, B ;
Wolfel, T ;
Boon, T ;
Lethe, B .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (01) :224-230
[6]  
BuendiaEisman A, 1997, EUR J DERMATOL, V7, P522
[7]   PROGNOSTIC-SIGNIFICANCE OF HYPOPIGMENTATION IN MALIGNANT-MELANOMA [J].
BYSTRYN, JC ;
RIGEL, D ;
FRIEDMAN, RJ ;
KOPF, A .
ARCHIVES OF DERMATOLOGY, 1987, 123 (08) :1053-1055
[8]   MASS-SPECTROMETRIC IDENTIFICATION OF A NATURALLY PROCESSED MELANOMA PEPTIDE RECOGNIZED BY CD8(+) CYTOTOXIC T-LYMPHOCYTES [J].
CASTELLI, C ;
STORKUS, WJ ;
MAEURER, MJ ;
MARTIN, DM ;
HUANG, EC ;
PRAMANIK, BN ;
NAGABHUSHAN, TL ;
PARMIANI, G ;
LOTZE, MT .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (01) :363-368
[9]   SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION [J].
CHOMCZYNSKI, P ;
SACCHI, N .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :156-159
[10]   IDENTIFICATION OF PIGMENT CELL ANTIGENS DEFINED BY VITILIGO ANTIBODIES [J].
CUI, J ;
HARNING, R ;
HENN, M ;
BYSTRYN, JC .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1992, 98 (02) :162-165